| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30020145 | HIV | ENSG00000120659.16 | protein_coding | TNFSF11 | No | No | 8600 | O14788 Q5T9Y4 |
| TVIS20039495 | HPV | ENSG00000120659.16 | protein_coding | TNFSF11 | No | No | 8600 | O14788 Q5T9Y4 |
| TVIS44000612 | HTLV-1 | ENSG00000120659.16 | protein_coding | TNFSF11 | No | No | 8600 | O14788 Q5T9Y4 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TNFSF11 |
|---|---|
| DrugBank ID | DB06511 |
| Drug Name | AMGN-0007 |
| Target ID | BE0003517 |
| UniProt ID | O14788 |
| Regulation Type | |
| PubMed IDs | 12548591 |
| Citations | Body JJ, Greipp P, Coleman RE, Facon T, Geurs F, Fermand JP, Harousseau JL, Lipton A, Mariette X, Williams CD, Nakanishi A, Holloway D, Martin SW, Dunstan CR, Bekker PJ: A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer. 2003 Feb 1;97(3 Suppl):887-92. |
| Groups | Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |